Shoulder Dysfunction - Biodex

More documents

Recommendations

Info

REPORTS: • Passive and Active Range of Motion: FLEX/EXT, ER/IR and ABD/ADD • Pain scale • Level of cardiovascular fitness: Establish: distance traveled, speed attained and duration of exercise • Biodex bilateral proprioception for ER/IR at 90º/90º • Biodex bilateral isometric comparison for FLEX/EXT, ER/IR @ modified neutral and ABD/ADD • Biodex bilateral isokinetic comparison for ER/IR in modified neutral • *Closed chain stability test *NOTE: There has been current research to denote the importance of closed chain exercises in the upper extremity. To date, there has been limited research on the validity and reliability of closed chain testing. The individual clinician should evaluate this test on an individual patient basis. 1-22 PHASE III: INITIAL AND INTERMEDIATE STRENGTHENING
GOALS: (for return to full activity) • Full pain free PROM and AROM • No complaint of pain throughout the ROM (especially at end ranges) • No inflammation/effusion • No complaints of palpable tenderness • Increase wrist and elbow ROM and strength • Continue to develop voluntary and involuntary control of shoulder stabilizers • Increase cardiovascular conditioning • Increase functional activity levels with no complaints of pain • Proprioception: ER/IR 90/90 < 10% deficit bilaterally • Isometric strength: 10% greater for the involved extremity* in all directions • Isokinetic strength: equal bilaterally or meet criteria for throwing *NOTE: The posterior "biased" shoulder involves specific unilateral muscle group ratios with the goal of a 10%: increases in the unilateral ratio. 11 There have been studies that have noted no statistical difference between dominant and non-dominant shoulder as well. 19,34 • Activity specific tests WNL • Isokinetic criteria for return to throwing:* 31 External Rotation: 98-105% Internal Rotation: 105-115% Abduction: 100-110% Adduction: 110-125% ER/IR ratio: 66-70% ABD/ADD ratio: 85-95% ER Peak torque to body weight ratio: 18-22% IR Peak torque to body weight ratio: 28-32% ABD Peak torque to body weight ratio: 24-30% ADD Peak torque to body weight ratio: 32-38% *All data represents 180 deg/sec PHASE IV return to activity © BIODEX MEDICAL SYSTEMS, INC. 1-23
Page 1 and 2: FN: 03-028 Evidence-based Clinical
Page 3 and 4: INTRODUCTION clinical protocol The
Page 5 and 6: GOALS: • Mentally prepare patient
Page 7 and 8: CLINICAL TREATMENT OPTIONS: • Reh
Page 9 and 10: SUPERVISED PROGRAM: • Control ede
Page 11 and 12: GOALS: • Full pain free PROM and
Page 13 and 14: CLINICAL TREATMENT OPTIONS: • Red
Page 15 and 16: SUPERVISED PROGRAM: • Range of Mo
Page 17 and 18: GOALS: • Full pain free PROM and
Page 19 and 20: CLINICAL TREATMENT OPTIONS: • Con
Page 21 and 22: CLINICAL TREATMENT OPTIONS (cont):
Page 23: HOME PROGRAM: • Control pain and
Page 27 and 28: CLINICAL TREATMENT OPTIONS: • Red
Page 29 and 30: CLINICAL TREATMENT OPTIONS (cont):
Page 31 and 32: HOME PROGRAM: • Control pain and
Page 33 and 34: 23. Mosely, BJ, Jobe, FW, Pink, M,
Page 35: EVIDENCE BASED CLINICAL PROTOCOL FO

Shoulder Dysfunction - Biodex

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?